Design of a core-shelled polymer cylinder for potential programmable drug delivery

被引:18
作者
Qiu, LY
Zhu, KJ
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310006, Peoples R China
[2] Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China
关键词
programmable drug delivery; polyanhydride; polyphosphazene;
D O I
10.1016/S0378-5173(01)00644-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A cylindrical dosage form comprising a laminated composite polymer core and a hydrophobic polycarbonate coating was proposed for programmable drug delivery. In the core, poly[(ethyl glycinate) (benzyl amino acethydroxamate) phosphazene] was synthesized as drug-loaded layers for its strong pH-sensitive degradation (eroded after 1.5 days at pH 7.4 and more than 20 days at pH 5.0 and 6.0). Poly(sebacic anhydride)-b-polyethylene glycol or poly(sebacic anhydride-co-trimellitylimidoglycine)-b-poly(ethylene glycol) was selected as isolating layers for their good processing properties at room temperature and suitable erosion duration. The in vitro drug release studies of these devices were conducted under physiological conditions (pH 7.4). The results revealed that the model drugs (brilliant blue, FITC-dextran, myoglobin) could be released in typical pulsatile manner. Moreover, the duration time of drug release (24-40 h) and the lag time (18-118 h) could be separately regulated by the mass of polyphosphazene and the type or mass of polyanhydride. In this experiment, the cooperative effect of polyanhydrides and pH-sensitive degradable polyphosphazene was specially demonstrated, which offers a new idea to develop a programmable drug delivery system for single dose vaccine and other related applications. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 21 条
[1]   POLY[(AMINO-ACID-ESTER)PHOSPHAZENES] - SYNTHESIS, CRYSTALLINITY, AND HYDROLYTIC SENSITIVITY IN SOLUTION AND THE SOLID-STATE [J].
ALLCOCK, HR ;
PUCHER, SR ;
SCOPELIANOS, AG .
MACROMOLECULES, 1994, 27 (05) :1071-1075
[2]  
ALLCOCK HR, 1997, POLYM MAT SCI ENG, V76, P49
[3]  
AMER MS, 1994, Patent No. 006275819
[4]  
CAI J, 1997, POLYM INT, V42, P373
[5]   Development of a single-shot subunit vaccine for HIV-1. 5. Programmable in vivo autoboost and long lasting neutralizing response [J].
Cleland, JL ;
Lim, A ;
Daugherty, A ;
Barron, L ;
Desjardin, N ;
Duenas, ET ;
Eastman, DJ ;
Vennari, JC ;
Wrin, T ;
Berman, P ;
Murthy, KK ;
Powell, MF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (12) :1489-1495
[6]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[7]  
FORSE RA, 1995, Patent No. 005403590
[8]  
GIUSEPPE P, 1991, J CLIN ENDOCR METAB, V72, P607
[9]   UPDATE ON PULSATILE LUTEINIZING-HORMONE-RELEASING HORMONE-THERAPY IN MALES WITH IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM AND DELAYED PUBERTY [J].
GIUSTI, M ;
CAVAGNARO, P .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (05) :419-429
[10]  
HORBETT TA, 1983, POLYM PREPR-ACS, V24, P34